These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

59 related articles for article (PubMed ID: 19781159)

  • 1. [Recent research developments on associations between disease-causing genes and metabolic hypertrophic cardiomyopathy.].
    Zhang Y; Pu JL
    Zhonghua Xin Xue Guan Bing Za Zhi; 2009 Mar; 37(3):283-5. PubMed ID: 19781159
    [No Abstract]   [Full Text] [Related]  

  • 2. Molecular etiology of idiopathic cardiomyopathy in Asian populations.
    Kimura A; Ito-Satoh M; Hayashi T; Takahashi M; Arimura T
    J Cardiol; 2001; 37 Suppl 1():139-46. PubMed ID: 11433818
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular basis of hypertrophic and dilated cardiomyopathy.
    Marian AJ; Roberts R
    Tex Heart Inst J; 1994; 21(1):6-15. PubMed ID: 8180512
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Desmin mutations in a St. Petersburg cohort of cardiomyopathies.
    Kostareva A; Gudkova A; Sjoberg G; Kiselev I; Moiseeva O; Karelkina E; Goldfarb L; Schlyakhto E; Sejersen T
    Acta Myol; 2006 Dec; 25(3):109-15. PubMed ID: 17626518
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Hereditary cardiomyopathies: a review. Mutation of structural proteins a common cause of hereditary cardiomyopathy].
    Sjöberg G; Kostareva A; Sejersen T
    Lakartidningen; 2005 Mar 14-20; 102(11):845-7, 850-3. PubMed ID: 15835520
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Mutations in genes for sarcomeric proteins].
    Kimura A
    Nihon Rinsho; 2000 Jan; 58(1):117-22. PubMed ID: 10885298
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Hypertrophic cardiomyopathy and dilated cardiomyopathy in six members of a family].
    Tatsumi T; Sirayama T; Tatsukawa H; Kosugi Y; Okada T; Azuma A; Omori I; Inoue N; Shimoo K; Nakagawa T
    Kokyu To Junkan; 1988 Sep; 36(9):1023-8. PubMed ID: 3238180
    [No Abstract]   [Full Text] [Related]  

  • 8. [Clinical and molecular genetics of hypertrophic cardiomyopathy].
    Sepp R; Csanády M
    Orv Hetil; 1998 Aug; 139(33):1965-71. PubMed ID: 9734214
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mutational screening of phospholamban gene in hypertrophic and idiopathic dilated cardiomyopathy and functional study of the PLN -42 C>G mutation.
    Medin M; Hermida-Prieto M; Monserrat L; Laredo R; Rodriguez-Rey JC; Fernandez X; Castro-Beiras A
    Eur J Heart Fail; 2007 Jan; 9(1):37-43. PubMed ID: 16829191
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cardiomyopathy: molecular and immunological aspects (review).
    Takeda N
    Int J Mol Med; 2003 Jan; 11(1):13-6. PubMed ID: 12469210
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genetics of hypertrophic cardiomyopathy: one, two, or more diseases?
    Bos JM; Ommen SR; Ackerman MJ
    Curr Opin Cardiol; 2007 May; 22(3):193-9. PubMed ID: 17413275
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular diagnostics of cardiomyopathies: the future is here.
    Bagnall RD; Ingles J; Semsarian C
    Circ Cardiovasc Genet; 2011 Apr; 4(2):103-4. PubMed ID: 21505198
    [No Abstract]   [Full Text] [Related]  

  • 13. Coexistence of Digenic Mutations in Both Thin (TPM1) and Thick (MYH7) Filaments of Sarcomeric Genes Leads to Severe Hypertrophic Cardiomyopathy in a South Indian FHCM.
    Selvi Rani D; Nallari P; Dhandapany PS; Rani J; Meraj K; Ganesan M; Narasimhan C; Thangaraj K
    DNA Cell Biol; 2015 May; 34(5):350-9. PubMed ID: 25607779
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mitochondrial cardiomyopathy: molecular and biochemical analysis.
    Marin-Garcia J; Goldenthal MJ
    Pediatr Cardiol; 1997; 18(4):251-60. PubMed ID: 9175519
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Genetic and molecular biological aspects on cardiomyopathies].
    Nishi H; Koga Y
    Nihon Naika Gakkai Zasshi; 1993 Feb; 82(2):178-82. PubMed ID: 8492020
    [No Abstract]   [Full Text] [Related]  

  • 16. Genotype phenotype correlations of cardiac beta-myosin heavy chain mutations in Indian patients with hypertrophic and dilated cardiomyopathy.
    Rai TS; Ahmad S; Bahl A; Ahuja M; Ahluwalia TS; Singh B; Talwar KK; Khullar M
    Mol Cell Biochem; 2009 Jan; 321(1-2):189-96. PubMed ID: 18953637
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Significance of HLA analysis and penetrance of ASH in familial cardiomyopathy with coexisting hypertrophic and dilated-like types in two families].
    Kishimoto C; Tomioka N; Kawai C; Tamaki S; Kadota K; Maruya E; Saji H
    Kokyu To Junkan; 1986 Sep; 34(9):959-64. PubMed ID: 3786961
    [No Abstract]   [Full Text] [Related]  

  • 18. W4R variant in CSRP3 encoding muscle LIM protein in a patient with hypertrophic cardiomyopathy.
    Newman B; Cescon D; Woo A; Rakowski H; Erikkson MJ; Sole M; Wigle ED; Siminovitch KA
    Mol Genet Metab; 2005 Apr; 84(4):374-5. PubMed ID: 15781201
    [No Abstract]   [Full Text] [Related]  

  • 19. Clinical and Prognostic Profiles of Cardiomyopathies Caused by Mutations in the Troponin T Gene.
    Ripoll-Vera T; Gámez JM; Govea N; Gómez Y; Núñez J; Socías L; Escandell Á; Rosell J
    Rev Esp Cardiol (Engl Ed); 2016 Feb; 69(2):149-58. PubMed ID: 26507537
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Between Disease-Causing and an Innocent Bystander: The Role of Titin as a Modifier in Hypertrophic Cardiomyopathy.
    Gerull B
    Can J Cardiol; 2017 Oct; 33(10):1217-1220. PubMed ID: 28866075
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.